How are ApoB and menopause related?

The relationship between ApoB and menopause is well-documented in medical literature but is not directly addressed in the provided MyBody-X materials. ApoB (apolipoprotein B) is the primary protein of atherogenic lipoproteins (LDL, VLDL) and is considered a more precise cardiovascular risk marker than LDL cholesterol alone. During menopause, estrogen levels decline, leading to an increase in LDL particles and consequently ApoB. Estrogen promotes LDL receptor activity in the liver; its loss slows LDL clearance. Studies show that postmenopausal women have higher ApoB levels and a more unfavorable lipoprotein profile compared to premenopausal women. This contributes to the increased cardiovascular risk after menopause. The provided contexts contain no specific studies or recommendations on this topic. A MyBody-X test might measure ApoB, but interpretation should account for menopausal status. A single measurement without clinical context is insufficient. Evidence: human-moderate (generally accepted, but not from the given material). Sources: none.